Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

March 29, 2021 00:26:01
Episode Cover

ECMO for Cardiac Arrest and Massive PE

Despite continued advances in resuscitation, favorable outcomes for patients with OHCA who receive standard resuscitation remain dismal.  In recent years there has been significant...

Listen

Episode 0

February 05, 2019 00:30:53
Episode Cover

ED Sepsis Screening - Is qSOFA Really Better?

As EDs across the country strive to meet sepsis benchmark metrics, many have implemented a variety of screening tools. With the publication of Sepsis-3,...

Listen

Episode 0

April 28, 2023 00:27:21
Episode Cover

Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?

The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the...

Listen